Brain Imaging Devices Market Size & Trends
The global brain imaging devices market size was valued at USD 5.65 billion in 2024 and is expected to grow at a CAGR of 8.2% from 2025 to 2030. Technological advancements in brain imaging, such as improved resolution, functional imaging techniques, and non-invasive methods, are significantly enhancing diagnostic capabilities.
Key Highlights
North America brain imaging devices market was the leading global market with the highest revenue share of 39.2% in 2024.
The U.S. brain imaging devices market captured the highest share of the regional market in 2024.
In product segment, the devices segment led the market with the highest revenue share of 81.5% in 2024.
In application segment, the brain tumor segment captured the highest revenue share in 2024.
On the modality segment basis, the fixed segment was the leading modality segment in the brain imaging devices market with the highest revenue share in 2024.
The surging occurrence of brain and neurological diseases such as Alzheimer's, Parkinson's disease, and stroke is also propelling the demand for these cutting-edge imaging solutions further. Physicians and researchers increasingly depend upon advanced brain imaging devices to identify, track, and treat these diseases properly. The growth in the market is expected to be fueled by the presence of different brain imaging technologies, such as magnetic resonance imaging (MRI), computed tomography (CT), Magnetoencephalography (MEG), Electroencephalography (EEG), and PET scanners, that provide applications for both structural and functional imaging. Other trends, including the integration of AI, the innovation of wearable brain imaging devices, and others, are also expected to contribute to this growth. For example, Hyperfine, Inc. released FDA clearance of the world's first mobile magnetic resonance brain imaging system -the Swoop system in January 2024 . They launched the eighth generation of its AI-advanced Swoop system software. This new release substantially improves the image quality generated by the Swoop system and provides significant improvements in usability, such as a real-time support feature for enhanced accuracy of patient positioning and simplified image upload process.
Some of the initiatives taken by the government for awareness and treatment of neurological diseases are likely to support market growth. For example, in 2022, member states at the World Health Assembly agreed to adhere to a new plan referred to as the Intersectoral global action plan on epilepsy and other neurological disorders for 2022-2031 (IGAP). This plan is targeting neurological disorders, which previously were not given sufficient attention. The plan gives a comprehensive map to countries on how to improve preventing, early detection, treating, and assisting individuals to recover from neurological disorders. IGAP defines particular objectives and measures to enhance availability of treatment and care for individuals with these conditions, facilitate brain health, enhance research and surveillance, and adopt a public health approach to address epilepsy and other neurological conditions.
The Intersectoral Global Action Plan 2022-2031 lays out a plan of action for countries to enhance prevention, early detection, treatment and recovery from neurological disorders. Towards equity and access to quality care, we must also invest in additional research on threats to brain health, better support for the health workforce, and proper services,
Report Coverage & Deliverables
- Competitive benchmarking
- Historical data & forecasts
- Company revenue shares
- Regional opportunities
- Latest trends & dynamics
Market Concentration & Characteristics
The stage of market growth is medium, and growth momentum is gaining strength. The brain imaging market has dramatically been altered through technology advances with a better accuracy, resolution, and speed in imaging results. Features like the integration of artificial intelligence, advanced algorithms for software, and compact imaging devices have enhanced diagnostic accuracy and allowed for quicker decision-making within clinics. These advancements have improved healthcare professionals' workflow and popularized brain imaging, particularly in outlying or underserved regions. Further, the increased prevalence of brain diseases has increased the need for advanced imaging equipment, fueling ongoing research, investment, and product innovation in the sector.
The dominant players in the market are continuously seeking to advance their product line in a bid to increase their customer base and acquire a greater percentage of the market. This includes product upgrading, looking at acquisitions, securing government approvals, and strategic partnerships. For example, in February 2024, Neuro42, Inc.-a developer of MRI and robotic solutions for diagnosing and treating brain disorders-obtained FDA clearance for its portable diagnostic MRI scanner. This innovation eradicates the requirement to move patients to dedicated imaging suites, allowing for instant diagnosis and enhanced treatment outcomes for patients suffering from severe neurological disorders.
Brain imaging technology has been revolutionized through technological innovation, placing it at the forefront of contemporary medical diagnostics. For instance, in February 2024, Indian firm InMed AI introduced a new device that applies artificial intelligence to identify severe brain injuries. The device, Neuroshield CT TBI, helps medical practitioners by detecting and measuring intracranial hemorrhage, fractures, and midline shifts. It achieves this by rapidly scanning brain CT images and informing physicians of any important results.
Obtaining government clearances is critical for competitiveness in the market, particularly when demand for neurology-based medical imaging equipment keeps increasing. In June 2023, for example, Ezra obtained FDA clearance for its groundbreaking AI-driven technology, Ezra Flash, which is expected to make brain imaging procedures better. Ezra Flash is tailored to provide better MRI scans.
“Our mission at Ezra is to detect cancer early for everyone in the world, and I’m really excited about this new AI enabling us to make our scans more affordable. By boosting quality while reducing scan time, we’re cutting the cost of a full-body MRI by 30% and passing these savings on to our customers.”
- Emi Gal, Founder and CEO, Ezra
The market for brain imaging equipment is growing geographically at a moderate to high rate due to population growth, rising healthcare expenditure, and changing regulatory landscapes. For example, in March 2024, Wipro GE Healthcare's Indian arm-an established name in medical technology-announced plans to bring 40 new products to market. This move demonstrates the company's intent on manufacturing in India with the goal of covering domestic and foreign markets.
Product Insights
The devices segment held the largest revenue share of 81.5% in 2024 owing to the augmented need for sophisticated diagnostic devices. The segment includes devices employed in brain imaging and functional scanning, such as CT, MRI, MEG, EEG, PET, and other devices like sleep monitors and electromyography machines. Of these, MRI enjoyed a substantial market share in 2024, owing mainly to its ability to perform functional magnetic resonance imaging (fMRI), which is able to monitor changes in oxygen and blood flow related to brain activity. The method makes use of the scanner's magnetic field to manipulate the magnetic nuclei of hydrogen atoms, allowing measurement and transformation into high-resolution images.
In addition, the electroencephalography (EEG) devices market will be the fastest-growing device segment to grow from 2024 to 2030. EEG devices capture the electrical brain activity and aid in the diagnosis of neurological disorders like epilepsy and sleep disorders. They are also being used more and more in neurofeedback therapy and brain-computer interfaces. Advances in technology in EEG devices are driving the growth of the segment. Current EEG systems are more sophisticated, providing greater resolution, better portability, and more intuitive interfaces. The use of artificial intelligence (AI) and machine learning (ML) in EEG analysis is revolutionizing the field of neurological research and clinical diagnostics.
AI algorithms are capable of processing and analyzing complicated EEG data more rapidly and accurately than conventional techniques. This ability expands the diagnostic process for diseases such as epilepsy, allowing for quicker and more accurate seizure detection. Additionally, AI-assisted EEG analysis creates new opportunities for personalized medicine, where treatments may be adjusted to suit an individual's specific brain activity patterns. For instance, in April 2024, researchers from the Creativity Research Lab at Drexel University created an artificial intelligence technique able to precisely measure an individual's brain age via EEG scans. This technology has the potential to facilitate early and regular screenings for neurodegenerative diseases. The research appeared in the Frontiers in Neuroergonomics journal.
"Brain MRIs are costly, and up to this point, brain-age estimation has only occurred in neuroscience research labs.". But my team and I have also created a machine-learning tool to estimate the brain age of an individual by employing a low-cost EEG device. It can be employed as a comparatively low-cost means for screening large groups of individuals for susceptibility to age-related illnesses. And due to its low cost, an individual can be screened at regular intervals in order to track changes over time. This can also be used to test the efficacy of drugs and other treatments. Even healthy people might employ this method to measure the effects of alterations in lifestyle as part of a comprehensive approach to maximizing brain performance.
- John Kounios, Ph.D., Professor, Drexel University College of Arts and Sciences, and Director of the Creativity Research Lab
The accessories category is expected to be the quickest-growing category at a CAGR of 9.2% between 2025 and 2030 driven by technological growth in imaging modalities, enhanced need for precise brain scans, and increased health awareness of neurological diseases that involve comprehensive diagnosis as well as observation. Critical elements of this segment-including electrodes, sensors, MRI machine coils, cables, batteries, and contrast agents-are improving image quality and are poised to reinforce main imaging equipment. Current research and development and future advancements and innovations in these accessories are key drivers of the overall performance and efficiency of brain imaging methods, hence leading to growth in this segment.
Application Insights
The brain tumor segment commanded the highest revenue share in 2024 due to the rising incidence of the disease. While brain tumor incidence is on the rise, there is greater demand for sophisticated imaging methods to correctly detect and track these tumors. The market for brain imaging technologies, especially those focused on tumor detection, is therefore predicted to observe substantial growth. For example, as per the International Agency for Research on Cancer, an estimated 321,731 new cases of brain and central nervous system cancer were reported in 2022 across the world. This form of cancer was ranked 19th out of all types of cancer.
The segment of epilepsy is likely to report the highest CAGR throughout the forecast period. Progress in imaging technologies has enhanced the possibility of detecting and diagnosing brain anomalies related to epilepsy, propelling demand for advanced imaging equipment. In addition, growing awareness of epilepsy and its neurological basis has created a stronger emphasis on early detection and intervention, fostering market growth. Furthermore, on-going R&D to enhance imaging modalities used for the diagnosis and tracking of epilepsy is driving innovation in the market and opening up wider opportunities for players in the industry. For example, in September 2022, scientists at the Indian Institute of Science (IISc), in association with AIIMS Rishikesh, reported designing an algorithm that could interpret brain scans to identify whether and what kind of epilepsy had occurred.
Modality Insights
The fixed segment held the largest revenue share in the brain imaging devices market in 2024. Fixed imaging devices capture high-resolution images of the brain, allowing for accurate diagnosis and treatment planning of brain disorders. Typically found in imaging centers, hospitals, and diagnostic facilities, these devices provide ease of access to both healthcare providers and patients interested in receiving proper neurological evaluation. Additionally, they frequently incorporate advanced functionality like multi-modal imaging and software-specific functionality, which improve diagnostic precision and versatility. Further, the increasing prevalence of neurological diseases has spurred the demand for effective brain imaging products, thus fueling the fixed imaging devices market.
The portable segment is expected to be the highest growth segment during 2025-2030. These devices are equipped with a number of benefits compared to the conventional fixed systems because they are mobile and flexible, which allows healthcare providers to conduct brain imaging procedures easily in numerous environments, such as clinics, ambulances, and remote areas. This portability also improves access to imaging services, particularly in areas with reduced healthcare infrastructure or in emergency situations when quick diagnosis is critical. The growth drivers in this segment are the expanding incidence of neurological disorders, the requirement for early and affordable diagnosis, the advancement in wearable technology, and enhanced interest in brain-computer interfaces (BCIs). Further, the need for continuous monitoring of brain health in routine settings is profoundly driving market growth. Emerging contenders are continuously working on the R&D of latest and new brain imaging devices in order to keep pace with growing competition. For example, in September 2023, EMVision was named as the number one innovator in the health section of the 2023 AFR BOSS Most Innovative Companies list-a validation of their pioneering advancements in healthcare innovation. The most impressive achievement of EMVision is its innovative portable brain-scanning technology, created to utilize cutting-edge imaging technologies for speedy, non-invasive evaluation of brain function and health. The system works based on electromagnetic imaging, with a mix of methods to provide vivid images of the structure and activity of the brain.
End Use Insights
The hospital segment maintained the highest revenue share in 2024. Hospitals are heavily involved in diagnosing and treating neurological conditions, which can sometimes demand sophisticated brain imaging equipment. These centers normally have funds available to spend on high-end devices, which makes them capable of providing extensive diagnostic solutions to patients. Furthermore, hospitals have multidisciplinary teams of professionals-neurologists, neurosurgeons, and radiologists-including various other professionals who work in coordination with each other to provide correct diagnosis as well as an effective treatment plan. The increasing worldwide incidence of neurological disorders is also likely to increase the demand for brain imaging equipment at hospitals, underscoring the critical need for accurate and timely diagnosis in the treatment of these illnesses.
The diagnostic imaging centers segment is likely to exhibit the highest CAGR over the forecast period. With greater realization of the need for early diagnosis and treatment of brain-related conditions, these centers are increasingly relied upon for their highly specialized equipment and technology. Diagnostic centers are also prompt in embracing new advances in imaging technology to ensure that diagnostic accuracy and efficiency remain high. For example, in March 2024, Fujifilm India made the announcement of installing its groundbreaking open MRI machine, APERTO Lucent, at the Vijaya Diagnostic Centre in Hyderabad. The accessibility and convenience provided by these centers are also driving their increasing adoption among patients.
Regional Insights
North America brain imaging devices market led the global market with the highest revenue share of 39.2% in 2024. Advances in brain imaging devices, including high-resolution MRI, PET scans, and functional MRI, greatly improve diagnostic capabilities and drive market growth in North America. These advances are enhancing accuracy and speed in detecting neurological disorders. In addition, the increasing incidence of diseases, especially Alzheimer's, Parkinson's, and stroke, is stimulating higher demand for early and precise diagnostic equipment. Healthcare professionals are increasingly using these advanced imaging technologies to aid improved treatment planning and monitoring, further spurring the growth of the brain imaging devices market in the region.
Drivers like advanced healthcare infrastructure and heavy medical research and technology investments drive the growth of the market. This infrastructure aids in the adoption of new brain imaging technologies. Also, there are a large number of medical device companies and neuroscience research centers present in North America. Such organizations promote innovation and brain imaging device advancements, thus contributing to market growth in this region.
U.S. Brain Imaging Devices Market Trends
The United States brain imaging equipment market captured the largest regional market share in 2024, thanks to increasing emphasis on the early diagnosis of neurological conditions. Early diagnosis facilitates proper treatment and improved patient outcome, which in turn has led to greater use of advanced imaging technologies. In addition, the innovation towards creating portable and miniaturized brain imaging machines is increasing convenience and accessibility, enabling diagnostics to be conducted across numerous settings, such as remote locations and point-of-care sites. These technologies are enhancing delivery of healthcare and driving overall growth of the market in the U.S.
This growth is also due to prominent players in the market of this nation like GE Healthcare, Siemens Healthineers AG, and Koninklijke Philips N.V. Also, different measures implemented by market leaders are likely to support market growth. For example, in January 2024, Siemens Healthineers revealed that the FDA has approved the MAGNETOM Cima.X 3 Tesla (3T) magnetic resonance imaging scanner.
Europe Brain Imaging Devices Market Trends
The European brain imaging equipment market is expected to experience substantial growth during the forecast period. The incorporation of AI and machine learning technology into brain imaging equipment will propel the regional market by improving diagnostic accuracy, efficiency, and treatment planning. These technologies allow for more accurate detection of neurological disorders, including brain tumor, Alzheimer's, and stroke. In addition, the move towards targeted medicine is driving demand for sophisticated imaging technologies that address specific patient requirements. AI-based algorithms can parse vast amounts of data to offer personalized treatment plans, bettering patient care and boosting the growth of the brain imaging devices market in Europe.
The rising incidence of brain disorders in Europe, combined with enhancing awareness regarding the need for early diagnosis and treatment, is fueling demand for brain imaging equipment. Favorable reimbursement schemes and government efforts to enhance access to high-tech medical technologies are additionally fueling this demand. For example, the Human Brain Project (HBP) was a multi-national European collaborative effort that focused on the advancement of neuroscience and medicine and endeavoring to create brain-inspired information technology.
The UK brain imaging devices market is anticipated to expand as a result of technological innovation, which has driven the creation of more accurate and effective imaging devices. Medical facilities are increasingly making these devices a part of their equipment, and the nation's increasing research and development (R&D) efforts will further increase market expansion. In February 2024, Cerca Magnetics, the University of Nottingham spin-out, was funded USD 2.15 million. This investment forms part of a broader government investment of USD 48.37 million in the quantum industry in the UK, which is meant to fund research in wearable brain imaging technology with the intention of detecting dementia early.
The French market for brain imaging devices is anticipated to expand from 2024 to 2030 with the rising incidence of brain cancer, which requires the application of brain imaging devices. For example, as per the International Agency for Cancer Research, in 2022, brain and central nervous system cancers were observed in 41 cases, and the number is anticipated to increase to 164 cases by 2027.
Germany's brain imaging devices market is also anticipated to increase from 2024 to 2030. This is due to the accelerated population aging, which enhances the incidence of brain disorders like Alzheimer's disease. Moreover, the well-established healthcare system, highly qualified labor force, and high healthcare expenditure of the country drive this growth.
Asia Pacific Brain Imaging Devices Market Trends
Asia Pacific has been anticipated to be the most rapid-growing region with a CAGR of 9.4% during 2025-2030, driven by increasing healthcare investments and the aging population. Higher healthcare funding for healthcare infrastructure increases the accessibility of advanced diagnostic technology. Concurrently, the vulnerability of the aging population to neurological disorders like Alzheimer's and stroke increases demand for precise imaging solutions. These population changes, along with advances in medical technology, provide a positive setting for the growth of the market, encouraging the creation of more sophisticated and affordable brain imaging equipment throughout the region.
The rise in cases of brain-related disease and disorders in nations in the Asia Pacific region is compelling demand for sophisticated diagnostic equipment. Alzheimer's disease, Parkinson's disease, and stroke are on the rise in most countries due to the factors of aging populations, lifestyle, and increased awareness about diseases. Therefore, accurate and timely diagnosis is increasingly in demand, which can be offered by brain imaging equipment.
Japan Brain Imaging Devices Market Trends
Japan brain imaging devices market is anticipated to expand at the highest CAGR in the regional market over the forecast period, which is due to the emphasis of the country on technology growth and the broad usage of sophisticated solutions. For example, in November 2023, RapidAI, a healthcare technology company developing imaging analysis software, reported that it has achieved Class III Shonin clearance in Japan. In addition to this regulatory achievement, RapidAI launched a hybrid technology platform called Rapid Edge Cloud and a non-contrast CT solution for stroke detection in the Japanese market.
Latin America Brain Imaging Devices Market Trends
The Latin American market for brain imaging equipment is forecasted to experience modest growth over the forecast period. This is due to increasing awareness and knowledge about the significance of prompt diagnosis and detection of brain-related diseases among healthcare providers and the population as a whole. This growing awareness is boosting demand for sophisticated diagnostic tools, such as brain imaging and monitoring equipment, to identify and treat these conditions in a timely manner.
MEA Brain Imaging Devices Market Trends
The MEA brain imaging devices market is expected to increase in the future. There is an increasing incidence of brain disorders in many countries in the MEA region. Aging populations, lifestyles, and improving mental health awareness are factors that are leading to the growing number of these conditions. Hence, the market is demanding early diagnosis and treatment of brain disorders, increasing market growth for the brain imaging devices.
Key Companies & Market Share Insights
Some of the key companies in the brain imaging devices industry include GE HealthCare; Koninklijke Philips N.V.; Siemens Healthineers AG; Medtronic; and Canon Medical Systems Corporation.
-
Siemens Healthineers AG offers advanced medical technologies, including diagnostic imaging, laboratory diagnostics, and molecular medicine. The company provides solutions for healthcare providers to enhance patient care, improve efficiency, and drive innovation in medical treatments.
-
Medtronic provides a wide range of medical devices and therapies, including solutions for cardiovascular, diabetes, neurology, and surgical procedures. The company focuses on improving patient outcomes through innovative technologies and advanced healthcare solutions worldwide.
Key Brain Imaging Devices Companies
The following are the leading companies in the brain imaging devices market. These companies collectively hold the largest market share and dictate industry trends.
- GE Healthcare
- Koninklijke Philips N.V.
- Siemens Healthineers
- Medtronic
- Compumedics Limited
- MEGIN
- CTF MEG NEURO INNOVATIONS, INC
- FieldLine Inc
- Cerca Magnetics Limited
- Advanced Brain Monitoring, Inc.
- CANON MEDICAL SYSTEMS CORPORATION
- Natus
- Magstim EGI
- Cadwell Industries Inc.
- Nihon Kohden Corporation
- NeuroLogica Corp.
Recent Developments
-
In March 2024, Neurophet, a specialist in AI solutions for brain diseases, attended the AD/PD 2024, an international conference on Alzheimer's, Parkinson's, and related neurodegenerative diseases. At this conference, Neurophet introduces technologies to treat Alzheimer's disease, such as side effect analysis tools and amyloid positivity prediction tools, which are close to being commercialized.
In March 2024, FUJIFILM India launched the Echelon Synergy MRI Machine at its CT & MRI User Conclave. Being a major leap in healthcare technology, the Echelon Synergy provides unparalleled performance, fast examination times, energy efficiency, and affordability.
Philips, in partnership with Synthetic MR, released Smart Quant Neuro 3D for the diagnosis and assessment of therapy performance for brain illnesses like multiple sclerosis (MS), traumatic brain injury (TBI), and dementia in February 2024. The Smart Quant Neuro 3D technology provides automated measurement of various brain tissues, brain disease decision support, monitoring of progression, and assessment of therapy outcome.
Brain Imaging DevicesMarket Report Scope
|
Report Attribute |
Details |
|
Market size value in 2025 |
USD 6.08 billion |
|
Revenue forecast in 2030 |
USD 9.03 billion |
|
Growth Rate |
CAGR of 8.2% from 2025 to 2030 |
|
Base year for estimation |
2024 |
|
Historical data |
2018 - 2023 |
|
Forecast period |
2025 - 2030 |
|
Quantitative units |
Revenue in USD million/billion and CAGR from 2025 to 2030 |
|
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
|
Segments covered |
Product, application, modality, end use, region |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; Mexico; U.K.; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; Australia; South Korea; Thailand; Brazil; Argentina; South Africa; Saudi Arabia; UAE; Kuwait |
|
Key companies profiled |
GE HealthCare; Koninklijke Philips N.V.; Siemens Healthineers AG; Medtronic; Compumedics Limited; MEGIN; CTF MEG NEURO INNOVATIONS, INC.; FieldLine Inc.; Cerca Magnetics Limited; Advanced Brain Monitoring, Inc.; Canon Medical Systems Corporation; Natus; Magstim EGI; Cadwell Industries Inc.; Nihon Kohden Corporation; and NeuroLogica Corp. |
|
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
|
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
Global Brain Imaging Devices Market Report Segmentation
Product Outlook (Revenue, USD Million, 2018 - 2030)
-
-
Devices
-
EEG
-
MEG
-
MRI
-
CT
-
PET
-
Other Devices
-
-
Accessories
-
Electrodes
-
Sensors
-
Other Accessories
-
-
-
Application Outlook (Revenue, USD Million, 2018 - 2030)
-
Stroke
-
Brain Tumor
-
Traumatic Brain Injury (TBI)
-
Epilepsy
-
Sleep Apnea
-
Headache
-
Structural Anomalies
-
Other Applications
-
-
Modality Outlook (Revenue, USD Million, 2018 - 2030)
-
Fixed
-
Portable
-
Wearable
-
-
End Use Outlook (Revenue, USD Million, 2018 - 2030)
-
Hospital
-
Diagnostic Imaging Centers
-
Ambulatory Surgery Centers
-
Other End Users
-
-
Regional Outlook (Revenue, USD Million, 2018 - 2030)
-
North America
-
U.S.
-
Canada
-
Mexico
-
-
Europe
-
U.K.
-
Germany
-
France
-
Italy
-
Spain
-
Denmark
-
Sweden
-
Norway
-
-
Asia Pacific
-
Japan
-
China
-
India
-
Australia
-
South Korea
-
Thailand
-
-
Latin America
-
Brazil
-
Argentina
-
-
Middle East & Africa
-
South Africa
-
Saudi Arabia
-
UAE
-
Kuwait
-
-
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy